{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:12:12Z","timestamp":1767136332025,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd013521","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T00:00:00Z","timestamp":1668384000000}}],"reference-count":111,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013521.pub2","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T08:07:53Z","timestamp":1668413273000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Statins for Smith-Lemli-Opitz syndrome"],"prefix":"10.1002","volume":"2022","author":[{"given":"Rami A","family":"Ballout","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Translational Vascular Medicine Branch; National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH); Bethesda MD USA"},{"name":"Department of Pediatrics; University of Texas Southwestern (UTSW) Medical Center and Children\u2019s Health; Dallas TX USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Livinski","sequence":"additional","affiliation":[{"name":"Division of Library Services; National Institutes of Health Library, Office of Research Services; Bethesda Maryland USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ping","family":"Fu","sequence":"additional","affiliation":[{"name":"Office of Biostatistics Research; National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH); Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D","family":"Steiner","sequence":"additional","affiliation":[{"name":"Marshfield Clinic Research Foundation; Marshfield Wisconsin USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan T","family":"Remaley","sequence":"additional","affiliation":[{"name":"Lipoprotein Metabolism Section, Translational Vascular Medicine Branch; National Heart, Lung and Blood Institute (NHLBI), National Institutes of Health (NIH); Bethesda MD USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD013521.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1203\/PDR.0b013e31819ea4eb","article-title":"Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome (SLOS)","volume":"65","author":"Chan","year":"2009","journal-title":"Pediatric Research"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10545-007-0537-7","article-title":"Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS)","volume":"30","author":"Haas","year":"2007","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"1-4","key":"10.1002\/14651858.CD013521.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/biof.5520320123","article-title":"Plasma and thrombocyte levels of coenzyme Q10 in children with Smith-Lemli-Opitz syndrome (SLOS) and the influence of HMG-CoA reductase inhibitors","volume":"32","author":"Haas","year":"2008","journal-title":"Biofactors"},{"issue":"5","key":"10.1002\/14651858.CD013521.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00431-012-1925-z","article-title":"Relation between biomarkers and clinical severity in patients with Smith-Lemli-Opitz syndrome","volume":"172","author":"Ol\u00e1h","year":"2013","journal-title":"European Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD013521.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s10545-012-9453-6","article-title":"No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome","volume":"35","author":"Roullet","year":"2012","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0006|cit6","unstructured":"Simvastatin therapy in smith-lemli-opitz syndrome clinicaltrials.gov\/show\/NCT00064792"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1212\/WNL.0000000000000565","article-title":"Variations in EEG discharges predict ADHD severity within individual Smith-Lemli-Opitz patients","volume":"83","author":"Schreiber","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/gim.2016.102","article-title":"A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome","volume":"19","author":"Wassif","year":"2017","journal-title":"Genetics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/09540260801889062","article-title":"Autism: the role of cholesterol in treatment","volume":"20","author":"Aneja","year":"2008","journal-title":"International Review of Psychiatry"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-60327-489-0_3","volume-title":"Autism. Current Theories and Evidence (Current Clinical Neurology collection)","author":"Aneja","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ymgme.2004.09.017","article-title":"3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome","volume":"84","author":"Correa-Cerro","year":"2005","journal-title":"Molecular Genetics and Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD013521.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s10545-005-0168-9","article-title":"Smith\u2013Lemli\u2013Opitz syndrome with a classical phenotype, oesophageal achalasia and borderline plasma sterol concentrations","volume":"28","author":"Haas","year":"2005","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"5","key":"10.1002\/14651858.CD013521.pub2-BIB0013|cit13","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1203\/01.PDR.0000146398.61649.74","article-title":"Cholesterol in childhood: friend or foe?","volume":"56","author":"Irons","year":"2004","journal-title":"Pediatric Research"},{"issue":"9060","key":"10.1002\/14651858.CD013521.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/S0140-6736(05)62415-4","article-title":"New treatment strategy for Smith-Lemli-Opitz syndrome","volume":"349","author":"Jira","year":"1997","journal-title":"Lancet"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0015|cit15","first-page":"175","article-title":"Smith-Lemli-Opitz syndrome: a disorder in cholesterol biosynthesis","volume":"22","author":"Jira","year":"1997","journal-title":"Nederlands Tijdschrift voor Klinische Chemie"},{"issue":"8","key":"10.1002\/14651858.CD013521.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0022-2275(20)33442-8","article-title":"Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome","volume":"41","author":"Jira","year":"2000","journal-title":"Journal of Lipid Research"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0017|cit17","volume-title":"The Smith-Lemli-Opitz syndrome: a multiple malformation syndrome due to a defect in cholesterol biosynthesis [PhD Thesis]","author":"Jira","year":"2005"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jmg.37.5.321","article-title":"The Smith-Lemli-Opitz syndrome","volume":"37","author":"Kelley","year":"2000","journal-title":"Journal of Medical Genetics"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD013521.pub2-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"S49\u2013S286","DOI":"10.1007\/s10545-011-9371-z","article-title":"Phenotypical properties and response to cholesterol therapy of Smith-Lemli-Opitz syndrome cases","volume":"34","author":"Kilic","year":"2011","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"Western Regiona","key":"10.1002\/14651858.CD013521.pub2-BIB0020|cit20","first-page":"54A","article-title":"Will dietary cholesterol decrease plasma cholesterol and decrease abnormal 7-dehydrocholesterol levels in Smith-Lemli-Opitz syndrome?","volume":"47","author":"Linck","year":"1999","journal-title":"Journal of Investigative Medicine"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0021|cit21","unstructured":"SLOS: the effect of simvastatin in patients receiving cholesterol supplementation clinicaltrials.gov\/show\/NCT01434745"},{"issue":"9","key":"10.1002\/14651858.CD013521.pub2-BIB0022|cit22","doi-asserted-by":"publisher","first-page":"eA121\u201369","DOI":"10.1515\/cclm-2018-0718","article-title":"Clinical significance of low cholesterol and high 7-dehydrocholesterol in inherited metabolic disorders","volume":"56","author":"Ol\u00e1h","year":"2018","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0023|cit23","first-page":"371","article-title":"Longitudinal cholesterol metabolite profiles in 20 patients with Smith-Lemli-Opitz-syndrome","volume":"167","author":"Palm","year":"2019","journal-title":"Monatsschrift fur Kinderheilkunde"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0024|cit24","first-page":"307","article-title":"Trienol a potential new marker of oxidative stress in Smith\u2013Lemli\u2013Opitz syndrome (SLOS)","volume":"102","author":"Pappu","year":"2011","journal-title":"Molecular Genetics and Metabolism"},{"issue":"16","key":"10.1002\/14651858.CD013521.pub2-BIB0025|cit25","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.1074\/jbc.M115.699546","article-title":"Cholesterol-mediated degradation of 7-dehydrocholesterol reductase switches the balance from cholesterol to vitamin D synthesis","volume":"291","author":"Prabhu","year":"2016","journal-title":"Journal of Biological Chemistry"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1590\/S1415-47572006000300003","article-title":"Smith-Lemli-Opitz syndrome: clinical and biochemical findings in Brazilian patients","volume":"29","author":"Scalco","year":"2006","journal-title":"Genetics and Molecular Biology"},{"issue":"6","key":"10.1002\/14651858.CD013521.pub2-BIB0027|cit27","first-page":"783","article-title":"Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome","volume":"144","author":"Sikora","year":"2004","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajmg.10722","article-title":"Simvastatin treatment in the SLO syndrome: a safe approach?","volume":"113","author":"Starck","year":"2002","journal-title":"American Journal of Medical Genetics"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1038\/s41413-019-0078-3","article-title":"Disruption of Dhcr7 and Insig1\/2 in cholesterol metabolism causes defects in bone formation and homeostasis through primary cilium formation","volume":"8","author":"Suzuki","year":"2020","journal-title":"Bone Research"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"S234","DOI":"10.1007\/s10545-015-9877-x","article-title":"Plasma lipids and proprotein convertase subtilisin\/kexin type 9 (PCSK9) in patients with Smith-Lemli-Opitz syndrome (SLOS)","volume":"38","author":"Tavori","year":"2015","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/978-1-4615-5901-6_5","article-title":"The Smith-Lemli-Opitz syndrome: a potentially fatal birth defect caused by a block in the last enzymatic step in cholesterol biosynthesis","volume":"28","author":"Tint","year":"1997","journal-title":"Sub-cellular Biochemistry"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0032|cit32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-2007-973760","article-title":"Smith-Lemli-Opitz syndrome: treatment with cholesterol and bile acids","volume":"27","author":"Ullrich","year":"1996","journal-title":"Neuropediatrics"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0033|cit33","first-page":"229A","article-title":"Investigation of simvastatin therapy in Smith-Lemli-Opitz syndrome","volume":"51","author":"Wright","year":"2002","journal-title":"Pediatric Research"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0034|cit34","first-page":"260","article-title":"Practice guidelines: ACC\/AHA release updated guideline on the treatment of blood cholesterol to reduce ASCVD risk","volume":"90","year":"2014","journal-title":"American Family Physician"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0035|cit35","first-page":"283","article-title":"The aberrant behavior checklist-community: factor validity and effect of subject variables for adults in group homes","volume":"100","author":"Aman","year":"1995","journal-title":"American Journal of Mental Retardation"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2133.2001.03964.x","article-title":"Cholesterol supplementation objectively reduces photosensitivity in the Smith-Lemli-Opitz syndrome","volume":"144","author":"Azurdia","year":"2001","journal-title":"British Journal of Dermatology"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1095\/biolreprod.112.102442","article-title":"The role of maternal-fetal cholesterol transport in early fetal life: current insights","volume":"88","author":"Baardman","year":"2013","journal-title":"Biology of Reproduction"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-66816-1_501-1","volume-title":"Genetic Syndromes","author":"Ballout","year":"2021"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ajmg.1320280320","article-title":"Female external genitalia and m\u00fcllerian duct derivatives in a 46, XY infant with the Smith-Lemli-Opitz syndrome","volume":"28","author":"Bialer","year":"1987","journal-title":"American Journal of Medical Genetics"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0040|cit40","unstructured":"Bikle D Vitamin D: Production, Metabolism, and Mechanisms of Action www.ncbi.nlm.nih.gov\/books\/NBK278935\/"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/hmg\/ddv507","article-title":"Reduced cholesterol levels impair smoothened activation in Smith-Lemli-Opitz syndrome","volume":"25","author":"Blassberg","year":"2016","journal-title":"Human Molecular Genetics"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1037\/0022-3514.63.3.452","article-title":"The aggression questionnaire","volume":"63","author":"Buss","year":"1992","journal-title":"Journal of Personality and Social Psychology"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1389-9457(99)00009-X","article-title":"Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems","volume":"1","author":"Chervin","year":"2000","journal-title":"Sleep Medicine"},{"issue":"22","key":"10.1002\/14651858.CD013521.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1002\/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M","article-title":"A simple method for converting an odds ratio to effect size for use in meta-analysis","volume":"19","author":"Chinn","year":"2000","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0045|cit45","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/nu2020116","article-title":"Dietary phospholipids and intestinal cholesterol absorption","volume":"2","author":"Cohn","year":"2010","journal-title":"Nutrients"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0047|cit47","unstructured":"Deeks JJ Higgins JP Altman DG on behalf of the Cochrane Statistical Methods Group Chapter 10: Analysing data and undertaking meta-analyses. In Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook of Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0048|cit48","first-page":"295","article-title":"Cognitive and behavioral aspects of Smith-Lemli-Opitz syndrome","volume":"160C","author":"Diaz-Stransky","year":"2012","journal-title":"Medical Journal of Medical Genetics"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00041433-200104000-00003","article-title":"Cholesterol metabolism in the brain","volume":"12","author":"Dietschy","year":"2001","journal-title":"Current Opinion in Lipidology"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10802-007-9098-3","article-title":"Estimates of the validity and utility of the Conners' Continuous Performance Test in the assessment of inattentive and\/or hyperactive-impulsive behaviors in children","volume":"35","author":"Edwards","year":"2007","journal-title":"Journal of Abnormal Child Psychology"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<305::AID-AJMG11>3.0.CO;2-X","article-title":"Clinical effects of cholesterol supplementation in six patients with Smith-Lemli-Opitz syndrome (SLOS)","volume":"68","author":"Elias","year":"1997","journal-title":"American Journal of Medical Genetics"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0053|cit53","unstructured":"EPOC resources for review authors; 2017 epoc.cochrane.org\/epoc-resources-review-authors"},{"issue":"14","key":"10.1002\/14651858.CD013521.pub2-BIB0054|cit54","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1073\/pnas.95.14.8181","article-title":"Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome","volume":"95","author":"Fitzky","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"10.1002\/14651858.CD013521.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI200112103","article-title":"7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz\/RSH syndrome","volume":"108","author":"Fitzky","year":"2001","journal-title":"Journal of Clinical Investigation"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41598-018-19592-8","article-title":"Prevention of retinal degeneration in a rat model of Smith-Lemli-Opitz Syndrome","volume":"8","author":"Fliesler","year":"2018","journal-title":"Scientific Reports"},{"issue":"9165","key":"10.1002\/14651858.CD013521.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S0140-6736(99)01163-0","article-title":"From effect size into number needed to treat","volume":"353","author":"Furukawa","year":"1999","journal-title":"Lancet"},{"issue":"21","key":"10.1002\/14651858.CD013521.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"8174","DOI":"10.1073\/pnas.0402680101","article-title":"Dynamic mapping of human cortical development during childhood through early adulthood","volume":"101","author":"Gogtay","year":"2004","journal-title":"Proceedings of the National Academy of Science of the United States of America"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.nu.03.070183.000443","article-title":"Absorption and metabolism of dietary cholesterol","volume":"3","author":"Grundy","year":"1983","journal-title":"Annual Review of Nutrition"},{"issue":"315","key":"10.1002\/14651858.CD013521.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"315ec201","DOI":"10.1126\/scitranslmed.aad5916","article-title":"Wanna be statin something?","volume":"7","author":"Henriques-Forsythe","year":"2015","journal-title":"Science Translational Medicine"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0061|cit61","unstructured":"Higgins JP Savovi\u0107 J Page MJ Elbers RG Sterne JA Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), Cochrane, 2017 Available from training.cochrane.org\/handbook\/archive\/v5.2"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0062|cit62","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ Welch VA Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0063|cit63","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0064|cit64","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 www.training.cochrane.org\/handbook"},{"issue":"7","key":"10.1002\/14651858.CD013521.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0022-2275(20)39745-5","article-title":"Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes","volume":"36","author":"Honda","year":"1995","journal-title":"Journal of Lipid Research"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0066|cit66","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2013.06.013","article-title":"Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz Syndrome (SLOS)","volume":"75","author":"Korade","year":"2014","journal-title":"Biological Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pd.5018","article-title":"Smith-Lemli-Opitz syndrome carrier frequency and estimates of in utero mortality rates","volume":"37","author":"Lazarin","year":"2017","journal-title":"Prenatal Diagnosis"},{"issue":"7","key":"10.1002\/14651858.CD013521.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/0002-9378(77)90713-X","article-title":"Placental transfer of cholesterol into the human fetus","volume":"128","author":"Lin","year":"1977","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD013521.pub2-BIB0069|cit69","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/1096-8628(20000828)93:5&lt;360::aid-ajmg4&gt;3.0.co;2-p","article-title":"Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome","volume":"93","author":"Linck","year":"2000","journal-title":"American Journal of Medical Genetics"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0070|cit70","unstructured":"Lloyd EE Self-mutilation in a community sample of adolescents digitalcommons.lsu.edu\/cgi\/viewcontent.cgi?article=7545&context=gradschool_disstheses"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1096-8628(20010108)105:1<36::AID-AJMG1053>3.0.CO;2-4","article-title":"Quantifying the phenotype in autism spectrum disorders","volume":"105","author":"Lord","year":"2001","journal-title":"American Journal of Medical Genetics"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nature Reviews: Molecular Cell Biology"},{"issue":"16","key":"10.1002\/14651858.CD013521.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1161\/01.CIR.0000145118.55201.15","article-title":"There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients","volume":"110","author":"McGowan","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0074|cit74","unstructured":"Simvastatin therapy in Smith-Lemli-Opitz syndrome clinicaltrials.gov\/show\/NCT00064792"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0075|cit75","unstructured":"Wells GA Shea B O'Connell D Peterson J Welch V Losos M Newcastle - Ottawa Quality Assessment Scale Case Control Studies www.ohri.ca\/programs\/clinical_epidemiology\/nosgen.pdf"},{"issue":"5","key":"10.1002\/14651858.CD013521.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/(SICI)1096-8628(19980806)78:5<419::AID-AJMG5>3.0.CO;2-G","article-title":"Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings","volume":"78","author":"Nowaczyk","year":"1998","journal-title":"American Journal of Medical Genetics"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0077|cit77","unstructured":"Nowaczyk MJ Wassif CA Smith-Lemli-Opitz Syndrome www.ncbi.nlm.nih.gov\/books\/NBK1143\/"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajmg.c.31343","article-title":"Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology","volume":"160C","author":"Nowaczyk","year":"2012","journal-title":"American Journal of Medical Genetics. Part C, Seminars in Medical Genetics"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0079|cit79","unstructured":"Nowaczyk MJ GeneReviews\u00ae. Smith-Lemli-Opitz Syndrome www.ncbi.nlm.nih.gov\/books\/NBK1116\/ 20301322"},{"issue":"3","key":"10.1002\/14651858.CD013521.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<315::AID-AJMG13>3.0.CO;2-W","article-title":"Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO\/RSH) syndrome","volume":"68","author":"Nwokoro","year":"1997","journal-title":"American Journal of Medical Genetics"},{"issue":"8","key":"10.1002\/14651858.CD013521.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/sleep\/23.8.1d","article-title":"The Children's Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children","volume":"23","author":"Owens","year":"2000","journal-title":"Sleep"},{"issue":"9","key":"10.1002\/14651858.CD013521.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/00004583-200209000-00006","article-title":"The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties","volume":"41","author":"The Research Units on Pediatric Psychopharmacology Anxiety Study Group","year":"2002","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"5285","key":"10.1002\/14651858.CD013521.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1126\/science.274.5285.255","article-title":"Cholesterol modification of hedgehog signaling proteins in animal development","volume":"274","author":"Porter","year":"1996","journal-title":"Science"},{"issue":"19","key":"10.1002\/14651858.CD013521.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"e009835","DOI":"10.1161\/JAHA.118.009835","article-title":"Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials","volume":"7","author":"Qu","year":"2018","journal-title":"Journal of the American Heart Association"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0085|cit85","unstructured":"Reeves BC Deeks JJ Higgins JP Shea B Tugwell P Wells GA on behalf of the Cochrane Non-Randomized Studies of Interventions Methods Group Chapter 24: Including non-randomized studies on intervention effects. In Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021 Available from training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0086|cit86","unstructured":"Review Manager 5 (RevMan 5) The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0088|cit88","unstructured":"Rosenson RS Statins: actions, side effects, and administration www.uptodate.com\/contents\/statins-actions-side-effects-and-administration"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0089|cit89","unstructured":"Rosenson RS Baker SK Statin muscle-related adverse events www.uptodate.com\/contents\/statin-muscle-related-adverse-events"},{"issue":"6","key":"10.1002\/14651858.CD013521.pub2-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archneur.61.6.889","article-title":"Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke","volume":"61","author":"Rundek","year":"2004","journal-title":"Archives of Neurology"},{"issue":"20","key":"10.1002\/14651858.CD013521.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1021\/bi00135a001","article-title":"Bile acid biosynthesis","volume":"31","author":"Russell","year":"1992","journal-title":"Biochemistry"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2004","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0093|cit93","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated 2013). GRADE Working Group, 2013 gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jclinepi.2018.01.012","article-title":"GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence","volume":"111","author":"Sch\u00fcnemann","year":"2019","journal-title":"Journal of Clinical Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD013521.pub2-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0026-0495(97)90133-5","article-title":"Rapid identification of Smith-Lemli-Opitz syndrome homozygotes and heterozygotes (carriers) by measurement of deficient 7-dehydrocholesterol-delta 7-reductase activity in fibroblasts","volume":"46","author":"Shefer","year":"1997","journal-title":"Metabolism"},{"issue":"6","key":"10.1002\/14651858.CD013521.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1037\/0012-1649.33.6.906","article-title":"Emotion regulation among school-age children: the development and validation of a new criterion Q-sort scale","volume":"33","author":"Shields","year":"1997","journal-title":"Developmental Psychology"},{"issue":"14","key":"10.1002\/14651858.CD013521.pub2-BIB0097|cit97","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/ajmg.a.31294","article-title":"The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome","volume":"140","author":"Sikora","year":"2006","journal-title":"American Journal of Medical Genetics Part A"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1582-4934.2001.tb00172.x","article-title":"Statins: mechanism of action and effects","volume":"5","author":"Stancu","year":"2001","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2796.2002.01037.x","article-title":"Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol-synthesis defect Smith-Lemli-Opitz syndrome","volume":"252","author":"Starck","year":"2002","journal-title":"Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013521.pub2-BIB0101|cit101","unstructured":"Page MJ Higgins JP Sterne JA Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"25 Pt B","key":"10.1002\/14651858.CD013521.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0103|cit103","first-page":"285","article-title":"Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders","volume":"160C","author":"Svoboda","year":"2012","journal-title":"American Journal of Medical Genetics"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-8628(20010115)98:2<191::AID-AJMG1030>3.0.CO;2-M","article-title":"Behavior phenotype in the RSH\/Smith-Lemli-Opitz syndrome","volume":"98","author":"Tierney","year":"2001","journal-title":"American Journal of Medical Genetics"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0105|cit105","first-page":"9","article-title":"Brain development and the role of experience in the early years","volume":"30","author":"Tierney","year":"2009","journal-title":"Zero Three"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajmg.a.33148","article-title":"Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome","volume":"152A","author":"Tierney","year":"2010","journal-title":"American Journal of Medical Genetics"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199401133300205","article-title":"Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome","volume":"330","author":"Tint","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/WCO.0000000000000405","article-title":"Genetic control of postnatal human brain growth","volume":"30","author":"Dyck","year":"2017","journal-title":"Current Opinion in Neurology"},{"issue":"4","key":"10.1002\/14651858.CD013521.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1023\/A:1005355026186","article-title":"Highly increased CSF concentrations of cholesterol precursors in Smith-Lemli-Opitz syndrome","volume":"20","author":"Rooij","year":"1997","journal-title":"Journal of Inherited Metabolic Disease"},{"issue":"2","key":"10.1002\/14651858.CD013521.pub2-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymgme.2004.12.009","article-title":"Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts","volume":"85","author":"Wassif","year":"2005","journal-title":"Molecular Genetics and Metabolism"},{"issue":"1","key":"10.1002\/14651858.CD013521.pub2-BIB0111|cit111","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013521","article-title":"Statins for Smith-Lemli-Opitz syndrome","author":"Ballout","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T10:28:05Z","timestamp":1754908085000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013521.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,11,14]]},"references-count":111,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013521.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,14]]}}}